Genasys Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +17.4% | -7.2% | +5.6% | +7.7% | +12.6% | +40.4% | +36.2% | -20.3% | -30.5% | +8.1% | +18.4% | |
| – | -16.6% | -7.4% | +15.4% | -4.7% | +23.0% | +17.9% | -11.5% | +0.2% | -29.1% | +3.7% | +50.3% | |
| – | -23.3% | -26.5% | -5.2% | -13.3% | +70.1% | +23.9% | -43.5% | -3.3% | -32.0% | -42.9% | +61.2% | |
| – | -18.1% | -16.2% | +4.4% | -14.4% | +53.6% | +22.5% | -31.7% | +1.5% | -47.0% | +27.0% | -37.6% | |
| – | -50.6% | +61.1% | +74.1% | -34.0% | -7.0% | +49.3% | +41.2% | +9.0% | -25.9% | -40.0% | +291.5% | |
| – | +26.5% | -3.3% | +10.4% | +28.1% | -13.4% | +2.0% | +7.9% | -6.4% | +8.2% | +12.5% | +20.4% | |
| – | – | +0.3% | +7.7% | +380.5% | -7.3% | +218.0% | -8.3% | -4.8% | – | – | – | |
| – | – | – | – | – | -5.7% | +7.2% | +864.2% | -57.5% | +1.6% | +29.6% | +0.9% | |
| – | +8.5% | +7.7% | -11.5% | +2,696.5% | -24.5% | -19.8% | +1,257.8% | -18.0% | -19.8% | +0.9% | -27.7% | |
| – | -66.1% | +30.2% | +63.8% | +127.9% | +40.2% | +45.0% | +42.0% | -11.2% | -25.0% | +126.0% | +69.6% | |
| – | -68.0% | +32.0% | +76.8% | +79.1% | +40.9% | +11.3% | +69.2% | -12.0% | -26.7% | +25.1% | +286.5% | |
| – | +311.6% | -75.9% | +0.0% | +50.5% | -5.6% | +282.5% | +11.6% | -20.7% | +6.3% | +1.3% | +1,774.1% | |
| – | -15.2% | -18.4% | +93.6% | +177.2% | -72.1% | +59.3% | +57.7% | +8.1% | +19.3% | +44.8% | +102.8% | |
| – | – | – | – | – | -37.2% | -45.3% | – | – | – | – | – | |
| – | +32.2% | -8.9% | +1.8% | -4.8% | +5.6% | +38.9% | +34.2% | -23.6% | -32.9% | -48.1% | -87.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | -4.8% | -0.4% | +2.0% | +2.8% | +2.1% | +4.4% | +2.5% | +1.2% | +20.0% | +1.7% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.